在肝细胞癌中,AIBP通过ERK1/2-MAPK信号通路促进细胞增殖和迁移
Tianxin Huang1,2, Sijia Ge1, Wei Huang1
1Department of Gastroenterology, Affiliated Hospital of Nantong University, Nantong, China.
脂蛋白A-I结合蛋白 (AIBP) 通过激活ERK/MAPK通路,促进肝细胞癌 (HCC) 的生长和扩散. 准AIBP可能为HCC治疗和诊断提供一个新的策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 肝细胞癌 (HCC) 是一种具有不良预后的侵袭性癌症,需要新的治疗策略.
- 参与胆固醇代谢和炎症的阿波脂蛋白A-I结合蛋白 (AIBP) 在HCC中起着未知的作用.
- 了解AIBP在HCC中的功能对于开发新疗法至关重要.
研究的目的:
- 调查AIBP在HCC扩散和迁移中的作用.
- 阐明潜在的分子机制,特别是基因激活蛋白激酶 (MAPK) 途径的参与.
主要方法:
- 使用癌症基因组图谱 (TCGA) 数据分析了AIBP表达和预后关联.
- 在HCC组织中通过免疫组织化学和西部涂抹评估AIBP水平.
- 评估了HCC细胞的增殖,迁移和入侵 *in vitro*和 *in vivo*.
主要成果:
- 在HCC组织中,AIBP表达显著升高,与预后不佳相关.
- 过度表达AIBP增强了HCC细胞的增殖,迁移和入侵 *in vitro*和 *in vivo*.
- AIBP调节了MAPK通路基因 (例如P-MEK,c-Myc,P-ERK1/2),其作用被ERK1/2抑制剂逆转.
结论:
- 通过激活ERK/MAPK信号通路,AIBP促进了HCC的进展.
- AIBP可以作为HCC的潜在预后和诊断生物标志物.
- 针对AIBP可能是HCC的有前途的治疗策略.
更多相关视频
07:32Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
08:50In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
Published on: April 18, 2025
相关概念视频
MAPK Signaling Cascades
PI3K/mTOR/AKT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Mitogens and the Cell Cycle
Inhibition of Cdk Activity
